Brooks Laboratories Board Meeting on Aug 13 to Review Q1 FY27 Results

Brooks Laboratories Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, along with the Limited Review Report from the statutory auditors. Additionally, the company confirmed the closure of the trading window for directors and designated persons from July 1, 2026, which will reopen 48 hours after the financial results are declared.